Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.

Williams B, Howell J, Doyle J, Thompson AJ, Draper B, Layton C, Latham N, Bramwell F, Membrey D, Mcpherson M, Roney J, Stoové M, Hellard ME, Pedrana A

(2019), Int J Drug Policy, 72, 91-8

DOI: 10.1016/j.drugpo.2019.05.012

Molecular dissection of an inhibitor targeting the HIV Integrase dependent pre-integration complex nuclear import.

Wagstaff KM, Headey S, Telwatte S, Tyssen D, Hearps AC, Thomas DR, Tachedjian G, Jans DA

(2019), Cell Microbiol, 21(1), e12953

DOI: 10.1111/cmi.12953

Effect of seminal plasma on functions of monocytes and granulocytes.

Selva KJ, Juno JA, Worley MJ, Chung AW, Tachedjian G, Kent SJ, Parsons MS

(2019), AIDS RES HUM RETROV, 35(6), 553-6

DOI: 10.1089/AID.2018.0219

Qualitative assessment of South African healthcare worker perspectives on an instrument-free rapid CD4 test.

Scorgie F, Mohamed Y, Anderson D, Crowe SM, Luchters S, Chersich MF

(2019), BMC Health Serv Res, 19(1), 123

DOI: 10.1186/s12913-019-3948-x

Hepatitis C risk perceptions and attitudes towards reinfection among HIV-diagnosed gay and bisexual men in Melbourne, Australia.

Schroeder SE, Higgs P, Winter R, Brown G, Pedrana A, Hellard M, Doyle J, Stoové M

(2019), J Int AIDS Soc, 22(5), e25288

DOI: 10.1002/jia2.25288

Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents.

Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K

(2019), Clin Liver Dis, 23(3), 521-34

DOI: 10.1016/j.cld.2019.04.012

Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Patients with Hematological and Solid Tumor Malignancies.

Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K

(2019), Clin Liver Dis, 23(3), 511-9

DOI: 10.1016/j.cld.2019.04.011

Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant Recipients.

Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K

(2019), Clin Liver Dis, 23(3), 493-509

DOI: 10.1016/j.cld.2019.04.010

Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology.

Sasadeusz J, Grigg A, Hughes PD, Lee Lim S, Lucas M, McColl G, McLachlan SA, Peters MG, Shackel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K

(2019), Clin Liver Dis, 23(3), 487-92

DOI: 10.1016/j.cld.2019.04.009

Performance of a novel low-cost, instrument-free plasma separation device for HIV viral load quantification and determination of treatment failure in people living with HIV in Malaysia: a diagnostic accuracy study.

Pham MD, Haile BA, Azwa I, Kamarulzaman A, Raman N, Saeidi A, Bador MK, Tan M, Zhu J, Yi F, Elliott JH, Garcia ML, Li F, Crowe SM, Luchters S, Anderson DA

(2019), J Clin Microbiol, 57(4), e01683-18

DOI: 10.1128/JCM.01683-18

Prevalence of baseline HCV NS5A resistance associated substitutions in genotype 1a, 1b and 3 infection in Australia

Papalucaa T, O’Keefe J,Bowden S, Doyle JS, Stoové M, Hellard M, Thompson AJ

(2019), J Clin Virol, 120, 84-7

DOI: 10.1016/j.jcv.2019.09.011

Outcomes of treatment for hepatitis C in prisoners using a nurse-led, state-wide model of care.

Papaluca T, McDonald L, Craigie A, Gibson A, Desmond P, Wong D, Winter R, Scott N, Howell J, Doyle J, Pedrana A, Lloyd A, Stoové M, Hellard M, Iser D, Thompson A

(2019), J Hepatol, 70(5), 839-46

DOI: 10.1016/j.jhep.2019.01.012

The prevalence of healthcare associated infections among adult inpatients at nineteen large Australian acute-care public hospitals: a point prevalence survey

Russo PL, Stewardson AJ, Cheng AC, Bucknall T, Mitchell BG

(2019), ANTIMICROB RESIST IN, 8, 114

DOI: 10.1186/s13756-019-0570-y

Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs

Latham NH, Pedrana A, Doyle JS, Howell J, Williams B, Higgs P, Thompson AJ, Hellard ME

(2019), J VIRAL HEPATITIS, 26(7), 919-22

DOI: 10.1111/jvh.13087

Staying hepatitis C negative: A systematic review and meta-analysis of cure and reinfection in people who inject drugs

Latham NH, Doyle JS, Palmer AY, Vanhommerig JW, Agius P, Goutzamanis S, Li Z, Pedrana A, Gottfredsson M, Bouscaillou J, Luhmann N, Mazhnaya A, Altice FL, Saeed S, Klein M, Falade-Nwulia OO, Aspinall E, Hutchinson S, Hellard ME, Sacks-Davis R

(2019), Liver Int, 39(12), 2244-60

DOI: 10.1111/liv.14152

Influences on surgical antimicrobial prophylaxis decision making by surgical craft groups, anaesthetists, pharmacists and nurses in public and private hospitals.

Ierano C, Thursky K, Peel T, Rajkhowa A, Marshall C, Ayton D

(2019), PLoS One, 14(11), e0225011

DOI: 10.1371/journal.pone.0225011

Appropriateness of Surgical Antimicrobial Prophylaxis Practices in Australia

Ierano C, Thursky K, Marshall C, Koning S, James R, Johnson S, Imam N, Worth LJ, Peel T

(2019), JAMA Netw Open, 2(11), e1915003

DOI: 10.1001/jamanetworkopen.2019.15003

Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure Prophylaxis

Lal L, Ryan K, Liu IY, Price B, Lockwood T, Aguirre I, Slobodian P, Lam A, Vassan M, Lim K, Silverii J, Tesoriero J, Phu J, Lim W, Naidoo B, Russell N, Rundle M, Sewell R, Cooper C, Hardman A, Quinn M, Mak A, Wright EJ

(2019), Front Pharmacol, 10, 1269

DOI: 10.3389/fphar.2019.01269

Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection

Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, Tee BK, Fairley CK, Chang CC, Armishaw J, Vujovic O, Penn M, Cundill P, Forgan-Smith G, Gall J, Pickett C, Lal L, Mak A, Spelman TD, Nguyen L, Murphy DA, Ryan KE, El-Hayek C, West M, Ruth S, Batrouney C, Lockwood JT, Hoy JF, Hellard ME, Stoové MA, Wright EJ; PrEPX Study Team

(2019), JAMA-J AM MED ASSOC, 321(14), 1380-90

DOI: 10.1001/jama.2019.2947

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy

Jaworowski A, Hearps AC, Angelovich TA, Hoy JF

(2019), Front Immunol, 10, 1378

DOI: 10.3389/fimmu.2019.01378

18 19 20 21 22